Project Details
Description
HM2021-05:A PHASE 1, MULTICENTER, OPEN-LABEL, DOSE FINDING STUDY OF CC-96673 IN SUBJECTS WITH RELAPSED OR REFRACTORY NON-HODGKIN S LYMPHOMA
| Status | Active |
|---|---|
| Effective start/end date | 3/11/21 → 3/31/26 |
Funding
- CELGENE CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.